"We are tremendously excited to be advancing this new direction in HIV vaccine design with Moderna's mRNA platform," Dr. Mark Feinberg, president and CEO of IAVI, said in a statement. "The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be the key to making rapid progress toward an urgently needed, effective HIV vaccine."Nearly 38 million people worldwide — including about 1.3 million in the U.
But despite decades of research, no vaccine has ever been developed. Several candidates have entered clinical trials but failed in later stages. According to the statement, Phase I of the trial will enroll 56 healthy, HIV-negative adult participants at GWU and three additional sites: Hope Clinic of Emory Vaccine Center in Atlanta; Fred Hutchinson Cancer Research Center in Seattle; and the University of Texas-Health Science Center at San Antonio.
Protect yourself people and show self control, it’s better than having unprotected sex and catching a virus 🦠 God Bless us all 🥰😇
People are dying inside more than outside because of this virus
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ScienceAlert - 🏆 63. / 68 Read more »